97 related articles for article (PubMed ID: 8001262)
1. The sensitivity to camptothecin of DNA topoisomerase I in L5178Y-S lymphoma cells.
Staron K; Kowalska-Loth B; Szumiel I
Carcinogenesis; 1994 Dec; 15(12):2953-5. PubMed ID: 8001262
[TBL] [Abstract][Full Text] [Related]
2. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
[TBL] [Abstract][Full Text] [Related]
3. Reduced sensitivity to camptothecin of topoisomerase I from a L5178Y mouse lymphoma subline sensitive to X-radiation.
Kowalska-Loth B; Staron K; Buraczewska I; Szumiel I; Kapiszewska M; Lange CS
Biochim Biophys Acta; 1993 Feb; 1172(1-2):117-23. PubMed ID: 8382526
[TBL] [Abstract][Full Text] [Related]
4. Effects of topoisomerase I-targeted drugs on radiation response of L5178Y sublines differentially radiation and drug sensitive.
Szumiel I; Buraczewska I; Gradzka I; Gasinska A
Int J Radiat Biol; 1995 Apr; 67(4):441-8. PubMed ID: 7738407
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of topoisomerase I in L5178Y-S cells is associated with poly(ADP-ribose) metabolism.
Staron K; Kowalska-Loth B; Nieznanski K; Szumiel I
Carcinogenesis; 1996 Mar; 17(3):383-7. PubMed ID: 8631120
[TBL] [Abstract][Full Text] [Related]
6. Discrepancy between the initial DNA damage and cell survival after camptothecin treatment in two murine lymphoma L5178Y sublines.
Gradzka I; Szumiel I
Cell Biochem Funct; 1996 Sep; 14(3):163-71. PubMed ID: 8888569
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the effect of camptothecin in x-irradiated L5178Y-R and L5178Y-S cells by benzamide.
Gradzka I; Iwaneńko T; Kruszewski M; Szumiel I; Kapiszewska M; Lange CS; Afanasjev G
Radiat Environ Biophys; 1996 Aug; 35(3):185-91. PubMed ID: 8880961
[TBL] [Abstract][Full Text] [Related]
8. DNA repair, cell cycle progression and cell death following camptothecin treatment in two murine lymphoma L5178Y sublines.
Gradzka I; Skierski J; Szumiel I
Cell Biochem Funct; 1998 Dec; 16(4):239-52. PubMed ID: 9857486
[TBL] [Abstract][Full Text] [Related]
9. Lowered phosphorylation of topoisomerase I is a direct reason for reduced sensitivity of L5178Y-S cells to camptothecin.
Staron K; Kowalska-Loth B; Szumiel I
Ann N Y Acad Sci; 1996 Dec; 803():321-3. PubMed ID: 8993529
[No Abstract] [Full Text] [Related]
10. Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains.
Evans HH; Ricanati M; Horng MF; Mencl J
Mutat Res; 1989 Jan; 217(1):53-63. PubMed ID: 2536134
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase I is differently phosphorylated in two sublines of L5178Y mouse lymphoma cells.
Staron K; Kowalska-Loth B; Zabek J; Czerwinski RM; Nieznanski K; Szumiel I
Biochim Biophys Acta; 1995 Jan; 1260(1):35-42. PubMed ID: 7999792
[TBL] [Abstract][Full Text] [Related]
12. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.
Eng WK; McCabe FL; Tan KB; Mattern MR; Hofmann GA; Woessner RD; Hertzberg RP; Johnson RK
Mol Pharmacol; 1990 Oct; 38(4):471-80. PubMed ID: 2172765
[TBL] [Abstract][Full Text] [Related]
13. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance.
Wang LF; Ting CY; Lo CK; Su JS; Mickley LA; Fojo AT; Whang-Peng J; Hwang J
Cancer Res; 1997 Apr; 57(8):1516-22. PubMed ID: 9108454
[TBL] [Abstract][Full Text] [Related]
14. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant defense system in differentially hydrogen peroxide sensitive L5178Y sublines.
Bouzyk E; Iwaneńko T; Jarocewicz N; Kruszewski M; Sochanowicz B; Szumiel I
Free Radic Biol Med; 1997; 22(4):697-704. PubMed ID: 9013132
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity to inhibitors of type II topoisomerases from mouse L5178Y lymphoma strains that are resistant or sensitive to X-radiation.
Staron K; Kowalska-Loth B; Szumiel I; Buraczewska I
Mutat Res; 1993 Feb; 285(2):175-9. PubMed ID: 7678889
[TBL] [Abstract][Full Text] [Related]
17. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin.
Kapoor R; Slade DL; Fujimori A; Pommier Y; Harker WG
Oncol Res; 1995; 7(2):83-95. PubMed ID: 7579731
[TBL] [Abstract][Full Text] [Related]
18. PKA controls a level of topoisomerase I mRNA in mouse L5178Y lymphoma cells treated with db-cAMP.
Czerwinski RM; Nieznanski K; Sochanowicz B; Staron K
Mol Biol Rep; 1994 Mar; 19(2):93-7. PubMed ID: 8072495
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins.
Taniguchi K; Kohno K; Kawanami K; Wada M; Kanematsu T; Kuwano M
Cancer Res; 1996 May; 56(10):2348-54. PubMed ID: 8625310
[TBL] [Abstract][Full Text] [Related]
20. Repair of gamma-ray-induced base damage in L5178Y sublines is damage type-dependent and unrelated to radiation sensitivity.
Kruszewski M; Zastawny TH; Szumiel I
Acta Biochim Pol; 2001; 48(2):525-33. PubMed ID: 11732621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
